Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0336-2022Class I

Cardiosave Hybrid IntraAortic Balloon Pump. Model Numbers: 0998-00-0800-31, 0998-UC-0800-31, 0998-00-0800-32...

Datascope Corp. / initiated 2021-11-15 / Open, Classified / root cause: design

Datascope Corp. began a recall of Cardiosave Hybrid IntraAortic Balloon Pump. Model Numbers: 0998-00-0800-31, 0998-UC-0800-31, 0998-00-0800-32, 0998-UC-0800-32, 0998-00-0800-33... on . FDA classified it as Class I and gives the reason as "Firm is initiating a correction due to the possibility of fluid ingress. Fluid entering the device may short various electronic components thus leading to system shutdown, which could result in unsafe hemodynamic...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-0336-2022
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Datascope Corp.
Product
Cardiosave Hybrid IntraAortic Balloon Pump. Model Numbers: 0998-00-0800-31, 0998-UC-0800-31, 0998-00-0800-32, 0998-UC-0800-32, 0998-00-0800-33, 0998-UC-0800-33, 0998-00-0800-34, 0998-UC-0800-34, 0998-00-0800-35, 0998-UC-0800-35, 0998-00-0800-36, 0998-UC-0800-36, 0998-00-0800-45, 0998-UC-0800-45, 0998-00-0800-52, 0998-UC-0800-52, 0998-00-0800-53, 0998-UC-0800-53, 0998-00-0800-55, 0998-UC-0800-55, 0998-00-0800-65, 0998-UC-0800-65.
Product code
DSP System, Balloon, Intra-Aortic And Control
Reason for recall
Firm is initiating a correction due to the possibility of fluid ingress. Fluid entering the device may short various electronic components thus leading to system shutdown, which could result in unsafe hemodynamic instability.
Root cause tag
design
FDA root cause
Device Design
Action
On November 15, 2021, the firm issued an Urgent Medical Device Correction letter to all affected consignees which informed them that the exterior of the Cardiosave Hybrid and Rescue IABP may be susceptible to fluid ingress at specific locations on the device. IABPs contain various electronic circuit boards. Liquid spills, such as saline, can create bridges of resistance between the circuit components; causing the circuit to not function as intended. This can impact initiation or continuation of counterpulsation therapy. Datascope/Getinge had previously issued an Urgent Medical Device Correction letter on April 26, 2018 to install a Top Protective Cover for the Cardiosave Hybrid IABP to help reduce the potential for fluid ingress. However, in some instances and depending on the volume of spill, this Top Protective Cover can overflow and fluid can enter the device in other susceptible areas. Consignees were requested to immediately examine inventory to determine if there is affected product on hand and that a correction should be available in 2022. Consignees were advised that in the meantime, continue to follow the IFU and adhere to the instructions when using the Cardiosave Hybrid and/or Rescue IABP In the unlikely event that a sudden interruption of therapy occurs, transfer the patient to an alternative IABP. If an alternative IABP is unavailable; manually inflate the IAB with air or helium and immediately aspirate, repeat every 5 minutes until either an alternate IABP is available or alternatively, the intra-aortic balloon catheter should be removed from the patient. The Intra-Aortic Balloon (IAB) Catheter Instructions for Use reinforces that the IAB catheter should not remain inactive (i.e. not inflating and deflating) for more than 30 minutes because of the potential for thrombus formation. Consignees were requested to forward this information to all current and potential affected. Distributors were also requested to forward the letter to customer atte
Quantity in commerce
5,566 (US); 6,354 (OUS)
Distribution
Worldwide distribution - US Nationwide.
Product codes and lots
All Serial Numbers. May also be designated as part number D998 etc. Model Number, UDI-DI: 0998-00-0800-31, 10607567109053; 0998-UC-0800-31, 10607567109053; 0998-00-0800-32, 10607567111117; 0998-UC-0800-32, 10607567111117; 0998-00-0800-33, 10607567109008; 0998-UC-0800-33, 10607567109008; 0998-00-0800-34, 10607567111940; 0998-UC-0800-34, 10607567111940; 0998-00-0800-35, 10607567109107; 0998-UC-0800-35, 10607567109107; 0998-00-0800-36, 10607567114187; 0998-UC-0800-36, 10607567114187; 0998-00-0800-45, 10607567108421; 0998-UC-0800-45, 10607567108421; 0998-00-0800-52, 10607567108438; 0998-UC-0800-52, 10607567108438; 0998-00-0800-53, 10607567108391; 0998-UC-0800-53, 10607567108391; 0998-00-0800-55, 10607567108414; 0998-UC-0800-55, 10607567108414; 0998-00-0800-65, 10607567113432; 0998-UC-0800-65, 10607567113432

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0336-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0336-2022Class IOngoingVoluntary: Firm initiated
Z-0337-2022Class IOngoingVoluntary: Firm initiated